|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 31/282 | |||
| A61K 31/337 | |||
| A61K 31/44 | |||
| A61K 31/4045 | |||
| A61K 31/69 | |||
| A61K 31/704 | |||
| A61K 45/06 | |||
| A61K 47/68 | |||
| A61K 39/395 | |||
| C07K 16/30 | |||
| G01N 33/574 | |||
| G01N 33/68 | |||
| C07K 16/28 |
| (11) | Number of the document | 2482848 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10821188.9 |
| Date of filing the European patent application | 2010-09-29 | |
| (97) | Date of publication of the European application | 2012-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/050759 |
| Date | 2010-09-29 |
| (87) | Number | WO 2011/041441 |
| Date | 2011-04-07 |
| (30) | Number | Date | Country code |
| 247290 P | 2009-09-30 | US | |
| 751907 | 2010-03-31 | US |
| (72) |
THEUER, Charles, US
VASQUEZ, Maximiliano, US
|
| (73) |
Tracon Pharmaceuticals, Inc.,
4350 La Jolla Village Drive Suite 800, San Diego, CA 92122,
US
|
| (54) | ENDOGLIN ANTIBODIES |
| ENDOGLIN ANTIBODIES |